Market revenue in 2023 | USD 75.2 million |
Market revenue in 2030 | USD 135.9 million |
Growth rate | 8.8% (CAGR from 2023 to 2030) |
Largest segment | Infectious diseases |
Fastest growing segment | Infectious Diseases |
Historical data | 2021 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Infectious Diseases |
Key market players worldwide | Danaher Corp, Kaneka Corp, TriLink BioTechnologies, Apex Biotechnology, BioNTech SE ADR, Lonza Group Ltd, Nunn’s Home Medical Equipment, EQT Corp, Catalent Inc, Samsung Electronics Co Ltd, Biomay AG, Indication, eTheRNA immunotherapies, BioCina |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to mrna therapeutics contract development & manufacturing market will help companies and investors design strategic landscapes.
Infectious diseases was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the South Africa mrna therapeutics contract development & manufacturing market based on infectious diseases covering the revenue growth of each sub-segment from 2021 to 2030.
Some of the key players are investing heavily in expanding their production capacities in South Africa. For instance, in February 2022, Moderna committed up to USD 500 million to construct an mRNA manufacturing plant in Africa with a production capacity of up to 500 million doses per year at the 50 g dose level.
This expansion aimed to support the local delivery of mRNA vaccines and therapeutics. Similarly, in December 2023, BioNTech announced an mRNA vaccine manufacturing facility in Kigali, Rwanda. The facility was associated with the BioNTainer, a digital modular manufacturing unit at the Kigali plant.
Thus, the growing demand for mRNA therapeutics creates opportunities for CDMO companies to support the increasing manufacture of mRNA therapeutics. This expansion aims to support the local delivery of mRNA vaccines and therapeutics in South Africa.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa mrna therapeutics contract development & manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa mrna therapeutics contract development & manufacturing market from 2021 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account